The third most cited study, “HLA-DR2 Dose Effect on Susceptibility to Multiple Sclerosis and Influence on Disease Course” (Barcellos et al., 2003), found that individuals with two copies of HLA-DRB1*15:01 had a significantly higher MS risk and worse disease progression. The gene discussed is HLA-DRB1; the disease is multiple sclerosis.